GMED Globus Medical Inc Class A

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Monday, March 10, 2025 at 4:30 pm Pacific Time

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it is scheduled to participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San Diego. Management is scheduled to present on Monday, March 10, 2025 at 4:30 pm PT.

Interested parties can access the live and archived webcast of the presentation in the “News & Events”, “Events & Webcasts” section of the Globus Medical investor relations website at .  

About Globus Medical, Inc. 

Based in Audubon, Pennsylvania, Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, regenerative biomaterials and enabling technologies. Additional information can be accessed at .  

Investor contact: 

Brian Kearns 

610-930-1800 

 

Media contact: 

Moran Chavez 

 



EN
06/03/2025

Underlying

GMEDGlobus Medical Inc Class A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Globus Medical Inc Class A

Free Trial
GMED Globus Medical ...

Globus Medical Inc: 1 director

A director at Globus Medical Inc sold 10,000 shares at 58.460USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

GMED GLOBUS MEDICAL INC CLASS A
09/16/25 September 16, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigatio...

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigation against Life Spine, Inc. The jury found that Life Spine’s Prolift family of implants infringed several claims of a valid Globus patent and awarded Globus both lost profits and reasonable royalty damages. The technology at issue involves expandable spinal fu...

August 28, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports Second Quarter 2025 Results

Globus Medical Reports Second Quarter 2025 Results AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025. Worldwide net sales were $745.3 million, an increase of 18.4%, or an increase of 17.6% on a constant currency basisGAAP net income for the quarter was $202.8 millionGAAP diluted earnings per share (“EPS”) was $1.49 and non-GAAP diluted EPS was $0.86 “Q2 results were led by our US Spine business, growing 5.7%, as reported and 7.4% on ...

August 7, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Announces Leadership Transitions and Preliminary Second...

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer effective July 18, 2025. Daniel Scavilla has resigned as President and Chief Executive Officer effective July 18, 2025, in order to pursue another opportunity. Additionally, Kyle Kline, Senior Vice ...

July 21, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Schedules Second Quarter Earnings Release and Conferenc...

Globus Medical Schedules Second Quarter Earnings Release and Conference Call AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Thursday, August 7, 2025. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call...

July 17, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch